Nanomedicine and Pharmaceutical Nanotechnology

About Conference

The 19^th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology will be held on November 25–26, 2026, in Paris, France. This premier international event brings together researchers, scientists, clinicians, pharmaceutical professionals, biotechnology experts, and industry leaders to discuss the latest advancements in nanomedicine and pharmaceutical nanotechnology.

Theme: Advancing Global Healthcare with Next-Generation Nanomedicine Solutions

The conference will feature cutting-edge research and innovations in Nanomedicine, Pharmaceutical Nanotechnology, Drug Delivery Systems, Cancer Nanotechnology, Nanodiagnostics, Biomaterials, Regenerative Medicine, Vaccines and Immunotherapy, Clinical Nanomedicine, Artificial Intelligence, and Smart Nano therapeutics.

Join global experts in Paris to exchange knowledge, foster collaborations, explore emerging technologies, and contribute to the future of healthcare through nanotechnology-driven innovation.

Why Attend?

Attend the Nanopharma 2026 to gain insights into the latest advancements in nanomedicine, drug delivery systems, pharmaceutical nanotechnology, biomaterials, and regenerative medicine. The conference offers an excellent platform to learn from global experts, present research, explore emerging technologies, network with industry leaders, and establish valuable collaborations. Participants will also discover new research opportunities, industry trends, regulatory developments, and innovative solutions that are shaping the future of healthcare and pharmaceutical sciences. This event provides a unique opportunity to exchange knowledge, foster partnerships, and contribute to the advancement of next-generation medical technologies.

Target Audience

The conference is designed for professionals, researchers, academicians, and industry experts involved in nanomedicine, pharmaceutical nanotechnology, and related healthcare disciplines. It provides an ideal platform for knowledge exchange, scientific collaboration, networking, and exploring the latest innovations shaping the future of medicine and pharmaceutical research.

• Researchers
• Scientists
• Academicians
• Pharmaceutical Professionals
• Nanotechnology Experts
• Biomedical Engineers
• Clinicians
• Healthcare Professionals
• Biotechnology Specialists
• Industry Leaders

Sessions/Tracks

Track 1: Nanomedicine

Nanomedicine is an interdisciplinary field that applies nanotechnology to the prevention, diagnosis, and treatment of diseases. By utilizing materials and devices at the nanoscale, researchers can develop highly precise therapeutic and diagnostic solutions that improve patient outcomes. Nanomedicine enables targeted drug delivery, enhanced imaging techniques, early disease detection, and personalized treatment approaches. This session will explore recent advancements in nanoparticle-based therapies, nanomaterials for biomedical applications, and innovative strategies for addressing major healthcare challenges. Discussions will focus on translational research, clinical applications, safety considerations, and future opportunities that are shaping the next generation of medical technologies and transforming healthcare delivery worldwide.

Track 2: Pharmaceutical Nanotechnology

Pharmaceutical nanotechnology focuses on the design, development, and application of nanoscale materials and systems to improve pharmaceutical products and therapies. Nanotechnology offers innovative solutions for enhancing drug solubility, stability, bioavailability, and therapeutic efficacy. This session will highlight advances in nanocarriers, nanoformulations, drug delivery platforms, and pharmaceutical manufacturing technologies. Researchers and industry experts will discuss emerging trends, regulatory challenges, quality control measures, and commercialization opportunities in Nano pharmaceutical development. Special emphasis will be placed on the role of nanotechnology in overcoming limitations of conventional drug delivery systems and creating safer, more effective treatments for a wide range of diseases and medical conditions.

Track 3: Drug Delivery Systems

Advanced drug delivery systems are revolutionizing healthcare by enabling controlled, targeted, and sustained release of therapeutic agents. These technologies improve treatment effectiveness while minimizing side effects and enhancing patient compliance. This session will cover innovative drug delivery approaches including nanoparticles, liposomes, micelles, hydrogels, and implantable systems. Participants will explore strategies for delivering drugs to specific tissues, cells, or disease sites with greater precision. Discussions will address challenges related to formulation design, biological barriers, pharmacokinetics, and clinical translation. The session aims to showcase cutting-edge research and emerging technologies that are driving the future of targeted and personalized medicine through improved drug delivery solutions.

Track 4: Targeted Therapeutics

Targeted therapeutics represents a significant advancement in modern medicine by focusing treatment directly on diseased cells while minimizing damage to healthy tissues. Nanotechnology plays a crucial role in enhancing targeting efficiency through engineered nanoparticles and smart delivery platforms. This session will explore innovative approaches to targeted therapy for cancer, infectious diseases, and chronic disorders. Topics include ligand-mediated targeting, receptor-specific delivery systems, stimulus-responsive nanocarriers, and precision medicine applications. Researchers will present breakthroughs in therapeutic design, efficacy evaluation, and clinical implementation. The session will provide insights into how targeted therapeutics are improving treatment outcomes and advancing the development of safer and more effective medical interventions.

Track 5: Cancer Nanotechnology

Cancer nanotechnology integrates nanoscience with oncology to improve cancer diagnosis, imaging, treatment, and monitoring. Nano scale materials offer unique advantages in targeting tumors, delivering anticancer drugs, and enhancing therapeutic effectiveness while reducing toxicity. This session will focus on novel nanoparticle-based drug delivery systems, Nano diagnostic tools, tumor-targeting strategies, and combination therapies. Discussions will examine recent clinical developments, translational research opportunities, and challenges associated with regulatory approval and commercialization. Participants will gain insights into the latest innovations that are transforming cancer care and contributing to the development of more personalized and effective treatment approaches for patients worldwide.

Track 6: Nanodiagnostics

Nanodiagnostics utilizes nanoscale technologies to improve disease detection, diagnosis, and monitoring. By enhancing sensitivity, specificity, and speed, nanodiagnostic tools enable earlier identification of diseases and more accurate clinical decision-making. This session will explore advancements in biosensors, imaging agents, lab-on-a-chip systems, and molecular diagnostic platforms. Topics include applications in cancer detection, infectious disease diagnosis, cardiovascular disorders, and personalized medicine. Researchers will discuss the integration of nanotechnology with diagnostic devices, challenges in clinical implementation, and opportunities for commercialization. The session highlights the growing role of nanodiagnostics in improving healthcare outcomes through innovative and highly efficient diagnostic solutions.

Track 7: Precision Medicine

Precision medicine aims to deliver individualized healthcare based on a patient’s genetic, environmental, and lifestyle characteristics. Nanotechnology supports this approach by enabling targeted therapies, personalized drug delivery, and advanced diagnostic tools. This session will focus on the integration of nanomedicine with precision healthcare strategies. Topics include biomarker identification, targeted therapeutic platforms, genomic medicine, and personalized treatment planning. Experts will discuss how nanoscale technologies are enhancing treatment effectiveness, reducing adverse effects, and improving patient outcomes. The session will also explore emerging trends and future directions in personalized healthcare supported by advances in nanotechnology and biomedical research.

Track 8: Vaccine Nanotechnology

Vaccine nanotechnology involves the use of nanoscale materials and delivery systems to improve vaccine efficacy, stability, and immune response. Nanoparticles can enhance antigen presentation, protect vaccine components, and enable controlled release mechanisms. This session will explore recent advances in nanoparticle-based vaccines, adjuvant technologies, and innovative immunization strategies. Topics include infectious diseases, pandemic preparedness, cancer vaccines, and next-generation vaccine platforms. Participants will discuss clinical developments, manufacturing challenges, and regulatory considerations. The session highlights how nanotechnology is transforming vaccine development and contributing to more effective disease prevention and global public health initiatives.

Track 9: Immunotherapy

Immunotherapy harnesses the body's immune system to prevent and treat diseases, particularly cancer and chronic infections. Nanotechnology enhances immunotherapeutic approaches by improving delivery efficiency, targeting specific immune cells, and reducing treatment-related toxicity. This session will explore nanotechnology-enabled immunotherapies, immune modulation strategies, vaccine-based therapies, and combination treatment approaches. Researchers will discuss recent scientific breakthroughs, clinical applications, and emerging opportunities in the field. The session aims to showcase innovative technologies that are strengthening immune responses and improving therapeutic outcomes while advancing the future of personalized and precision medicine.

Track 10: Lipid Nanoparticles

Lipid nanoparticles have emerged as a powerful platform for drug and gene delivery, particularly in mRNA-based therapeutics and vaccines. Their biocompatibility, stability, and delivery efficiency make them valuable tools in modern medicine. This session will examine the design, formulation, and clinical applications of lipid nanoparticle systems. Topics include nucleic acid delivery, targeted therapies, vaccine development, and pharmaceutical manufacturing. Discussions will focus on optimization strategies, safety considerations, and regulatory aspects. Participants will gain insights into the expanding role of lipid nanoparticles in advancing innovative therapies and improving healthcare outcomes.

Track 11: Nanocarriers

Nanocarriers are nanoscale delivery systems designed to transport therapeutic agents directly to targeted tissues or cells, improving drug efficacy while minimizing side effects. These carriers include liposomes, polymeric nanoparticles, dendrimers, micelles, and solid lipid nanoparticles. Their unique properties enable controlled drug release, enhanced bioavailability, and protection of therapeutic compounds from degradation. This session will explore recent advancements in nanocarrier design, targeted delivery strategies, and clinical applications across various therapeutic areas. Discussions will focus on formulation challenges, safety considerations, manufacturing technologies, and translational opportunities. Participants will gain insights into how Nano carriers are revolutionizing modern drug delivery and advancing the development of next-generation therapeutics.

Track 12: Biomaterials

Biomaterials are natural or synthetic materials engineered to interact with biological systems for therapeutic or diagnostic purposes. They play a critical role in medical devices, drug delivery systems, tissue engineering, and regenerative medicine. This session will highlight recent developments in biocompatible materials, smart biomaterials, Nano composites, and bioactive surfaces. Topics include material design, biological interactions, clinical applications, and emerging innovations. Researchers will discuss strategies to enhance functionality, durability, and patient safety while addressing current challenges in biomaterial development. The session aims to showcase how advanced biomaterials are contributing to improved healthcare solutions and supporting the evolution of modern biomedical technologies.

Track 13: Tissue Engineering

Tissue engineering combines principles of biology, engineering, and material science to develop functional tissues that can repair, replace, or regenerate damaged organs and tissues. Nanotechnology has significantly enhanced this field through advanced scaffolds, biomaterials, and cellular delivery systems. This session will focus on innovative approaches in tissue regeneration, scaffold fabrication, stem cell technologies, and bioengineering applications. Topics include bone, cartilage, skin, vascular, and organ tissue engineering. Participants will explore recent scientific breakthroughs, translational challenges, and clinical advancements. The session highlights the potential of tissue engineering to address critical healthcare needs and improve patient outcomes through regenerative solutions.

Track 14: Regenerative Medicine

Regenerative medicine aims to restore the structure and function of damaged tissues and organs using innovative biological and technological approaches. Nanotechnology enhances regenerative therapies through advanced biomaterials, stem cell delivery systems, and tissue repair strategies. This session will examine emerging developments in cell-based therapies, tissue regeneration, biomaterial engineering, and personalized regenerative treatments. Discussions will focus on clinical applications, translational research, manufacturing challenges, and regulatory considerations. Researchers and healthcare professionals will explore how regenerative medicine is transforming the treatment of chronic diseases, injuries, and degenerative disorders. The session emphasizes the future potential of regenerative technologies in improving healthcare and quality of life.

Track 15: Neurological Nanomedicine

Neurological nanomedicine applies nanotechnology to the diagnosis, treatment, and management of disorders affecting the brain and nervous system. Nanomaterials and targeted delivery systems offer promising solutions for overcoming the blood-brain barrier and enhancing therapeutic effectiveness. This session will cover innovative approaches for treating neurodegenerative diseases, brain tumors, stroke, epilepsy, and other neurological conditions. Topics include nanoparticle-based drug delivery, neuroimaging technologies, biosensors, and regenerative therapies. Researchers will discuss recent scientific advances, clinical applications, and future opportunities in neurological healthcare. The session highlights the transformative role of nanotechnology in improving diagnosis, treatment precision, and patient outcomes in neurology.

Track 16: Cardiovascular Nanomedicine

Cardiovascular nanomedicine focuses on the application of nanotechnology for the diagnosis, prevention, and treatment of heart and vascular diseases. Nanoparticles, targeted drug delivery systems, and advanced imaging agents offer new opportunities to improve cardiovascular care. This session will explore innovative approaches for treating conditions such as atherosclerosis, hypertension, myocardial infarction, and heart failure. Topics include nano-enabled therapeutics, cardiovascular imaging, regenerative strategies, and biomarker detection. Participants will discuss recent research advancements, clinical applications, and future directions in cardiovascular nanomedicine. The session aims to highlight the role of nanotechnology in enhancing treatment precision, reducing complications, and improving long-term patient outcomes.

Track 17: Infectious Disease Nanotechnology

Nanotechnology is playing a vital role in combating infectious diseases through advanced diagnostics, targeted therapies, and innovative vaccine platforms. This session will focus on the development of nanomaterial and Nano devices for the detection, prevention, and treatment of bacterial, viral, fungal, and parasitic infections. Topics include antimicrobial nanoparticles, rapid diagnostic tools, vaccine delivery systems, and emerging therapeutic strategies. Discussions will address challenges related to antimicrobial resistance, global health concerns, and pandemic preparedness. Participants will gain insights into how nanotechnology is transforming infectious disease management and contributing to more effective healthcare interventions worldwide.

Track 18: Nano Biosensors

Nano biosensors are highly sensitive analytical devices that combine biological recognition elements with nanomaterials to detect specific biological or chemical substances. These technologies offer rapid, accurate, and cost-effective diagnostic solutions. This session will explore recent developments in biosensor design, nanomaterial integration, and clinical applications. Topics include disease diagnostics, environmental monitoring, wearable health devices, and point-of-care testing. Researchers will discuss advances in sensor performance, miniaturization, and commercialization opportunities. The session highlights the growing importance of nano biosensors in modern healthcare and their potential to revolutionize disease detection and monitoring.

Track 19: Point-of-Care Diagnostics

Point-of-care diagnostics provide rapid testing and immediate results at or near the site of patient care. Nanotechnology enhances these diagnostic platforms by improving sensitivity, portability, and ease of use. This session will cover innovative diagnostic devices, lab-on-a-chip technologies, biosensing platforms, and mobile healthcare solutions. Topics include infectious diseases, chronic disease management, personalized medicine, and remote healthcare applications. Participants will explore current challenges, regulatory considerations, and commercialization pathways. The session emphasizes the role of nanotechnology in making healthcare more accessible, efficient, and responsive to patient needs.

Track 20: AI in Nanomedicine

Artificial Intelligence is transforming nanomedicine by accelerating research, optimizing nanoparticle design, and improving clinical decision-making. This session will examine the integration of AI, machine learning, and data analytics into nanotechnology-driven healthcare solutions. Topics include predictive modeling, drug discovery, personalized medicine, imaging analysis, and smart therapeutic systems. Researchers and industry professionals will discuss innovative applications, challenges, and future opportunities. The session aims to showcase how AI-powered technologies are enhancing the development of nanomedicines and supporting more precise, efficient, and effective healthcare interventions.

Track 21: Nanorobotics

Nanorobotics represents a groundbreaking field focused on the development of nanoscale machines capable of performing highly precise medical tasks within the human body. These tiny devices offer promising applications in targeted drug delivery, disease diagnosis, tissue repair, and minimally invasive procedures. This session will explore recent advances in nanorobot design, navigation systems, biomedical applications, and clinical potential. Discussions will address technical challenges, safety concerns, and future opportunities. Participants will gain insights into how Nano robotics could revolutionize healthcare by enabling highly accurate and personalized medical interventions.

Track 22: Clinical Nanomedicine

Clinical nanomedicine focuses on translating nanotechnology-based discoveries into practical medical applications and patient care. This session will highlight clinical trials, approved nanomedicine products, therapeutic innovations, and translational research initiatives. Topics include nanodrug formulations, targeted therapies, diagnostic technologies, and patient outcomes. Researchers, clinicians, and industry experts will discuss regulatory pathways, commercialization challenges, and strategies for successful clinical implementation. The session aims to bridge the gap between laboratory research and real-world healthcare applications while promoting the advancement of evidence-based nanomedicine.

Track 23: Nano pharmaceutical Regulations

The successful development of nanopharmaceuticals requires robust regulatory frameworks to ensure product quality, safety, and efficacy. This session will examine global regulatory guidelines, quality standards, risk assessment methodologies, and approval pathways for nanomedicine products. Topics include manufacturing practices, characterization techniques, clinical evaluation, and post-market surveillance. Regulatory professionals, researchers, and industry stakeholders will discuss current challenges and emerging regulatory trends. The session provides valuable insights into navigating the complex regulatory landscape and supporting the responsible development of innovative nanopharmaceutical products.

Track 24: Nanotoxicology

Nanotoxicology investigates the potential health and environmental risks associated with nanomaterials and nanotechnology-based products. Understanding the interactions between nanomaterials and biological systems is essential for ensuring their safe application in healthcare. This session will focus on toxicity assessment, biocompatibility studies, risk evaluation, and safety testing methodologies. Topics include nanoparticle behavior, cellular interactions, environmental impact, and regulatory requirements. Participants will discuss current research findings, standardization efforts, and best practices for minimizing risks. The session highlights the importance of safety evaluation in advancing responsible nanotechnology innovation.

Track 25: Nanotechnology Commercialization

Nanotechnology commercialization focuses on transforming innovative research discoveries into successful products and market-ready solutions. This session will explore technology transfer, intellectual property management, startup development, investment opportunities, and industry partnerships. Topics include product development strategies, regulatory considerations, manufacturing scale-up, and market adoption. Entrepreneurs, investors, researchers, and industry leaders will discuss challenges and success stories in bringing nanotechnology innovations to the marketplace. The session aims to promote collaboration between academia and industry while accelerating the commercialization of cutting-edge nanomedicine and pharmaceutical technologies for global healthcare advancement.

Market Analysis

The global nanomedicine and pharmaceutical nanotechnology market is experiencing remarkable growth, driven by increasing demand for targeted therapies, precision medicine, advanced drug delivery systems, and innovative diagnostic technologies. The market was valued at approximately USD 209.3 billion in 2024 and is projected to reach over USD 410 billion by 2030, growing at a Compound Annual Growth Rate (CAGR) of 11.6%. This growth is fueled by rising incidences of cancer, cardiovascular diseases, neurological disorders, diabetes, and infectious diseases, creating a strong demand for more effective and personalized healthcare solutions. Continuous advancements in nanoparticle engineering, nanocarriers, biomaterials, and nanodiagnostics are further accelerating market expansion and transforming modern medicine.

North America currently dominates the global nanomedicine market due to its strong research infrastructure, significant healthcare investments, and the presence of leading pharmaceutical and biotechnology companies. Europe remains a major contributor through collaborative research initiatives, supportive regulatory frameworks, and increasing adoption of nanotechnology-based healthcare products. Meanwhile, the Asia-Pacific region is emerging as the fastest-growing market, driven by expanding pharmaceutical manufacturing capabilities, growing healthcare expenditures, favorable government initiatives, and increasing investments in nanotechnology research and development. Countries such as China, India, Japan, and South Korea are playing a pivotal role in advancing innovation and commercialization within the sector.

The future of nanomedicine is being shaped by breakthroughs in artificial intelligence, smart nanotherapeutics, regenerative medicine, nanorobotics, gene and cell therapies, and next-generation vaccine technologies. Increasing collaboration between academia, healthcare institutions, biotechnology firms, pharmaceutical companies, and regulatory agencies is accelerating the translation of laboratory discoveries into clinical applications. As healthcare systems worldwide continue to focus on precision medicine and patient-centered care, nanomedicine is expected to become a cornerstone of future therapeutic and diagnostic strategies. This rapidly expanding market presents significant opportunities for scientific innovation, investment, commercialization, and global healthcare advancement, making it one of the most promising sectors in modern medicine.